AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. We operate in over 100 countries and our company is comprised of many voices, views and talents united by a common mission: helping people live healthier lives, embracing diverse perspectives, and working together to create a better future.

Science and patients are at the heart of everything we do, and our skills and resources are concentrated on those therapy areas where we believe we can make the most difference. We focus primarily on cancer, cardiovascular/metabolic disease and respiratory/inflammation/autoimmunity. Alongside this, we remain active in infection and neuroscience with targeted investments in opportunities and collaborations.

We know the world of science is changing at a rapid pace and we continue to focus on research and development, partnering with others to access the best science and accelerate the delivery of new medicines. Our scientific leadership has been active in building early stage biotech and academic alliances, alongside in-licensing and acquisitions to strengthen our pipeline and broaden the range of treatment options for physicians and patients.